Greydanus DE, Sloane MA, Rappley MD. Psychopharmacology of ADHD in adolescents.Adolesc Med 2002; 13: 599–624.
Greydanus DE, Pratt HD, Sloane MAet al. Attention-deficit/ hyperactivity disorder in Children and adolescents: Interventions for a complex costly clinical conundrum.Pediatr Clin North Am 2003; 50: 1049–1092.
Greydanus DE. Psychopharmacology of ADHD in adolescents: Quo vadis?Psychiatr Times 2003; 20: 5–9.
National Institute of Mental Health (NIMH).Attention Deficit Hyperactivity Disorder. NIMH, NIH Publication No. 01-4589, 2001. Available at: http://www.nimh.nih.gov/publicat/ helpchild.cfm.
National Institute of Mental Health.NIMH Research on Treatment for Attention Deficit Hyperactivity Disorder (ADHD): The Multimodal Treatment Study—Questions and Answers. Washington, DC: NIMH, 2000. Available at:http://www.nimh.nih.gov/events/mtaqa.cfm
National Institute of Health (NIH).Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. NIH Consensus Statement Online 1998: Nov 16–18; [cited year, month, day]; 16(2): 1–37.
Pratt HD. Neurodevelopmental Issues in the assessment and treatment of deficits in attention, cognition, and learning during adolescence.Adolesc Med 2002; 13(3): 579–598.
Reiff MI, Stein MT. ADHD evaluation and diagnosis: A practical approach to office practice.Pediatr Clin North Am 2003; 50: 1019–1048.
Staufer WB, Greydanus DE. Attention-devicit/hyperactivity disorder psychopharmacology for college students.Pediatr Clin North Am 2005; 52: 71–84.
Wolraich ML, Wibbelsman CJ, Brown TE. ADHD: A review.Pediatrics 2005; 115: 749–757.
The International Classification of Diseases, 10th ed. (ICD-10), WHO, 1993.
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders, 4th edn., Text Revision. Washington, DC: Author, 2000; 85–93.
Wolraich ML, Felice ME.The Classification of Child and Adolescent Mental Diagnoses in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC): Child and Adolescent Version. Elk Grove Village, IL; American Academy of Pediatrics, 1986, 93–110.
Barkley RA. Attention-deficit/hyperactivity disorder. Sci Am 1998; 66–71.
Barkley RA, ed.Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis, 2d edn. New York; Guilford Press, 1998.
Stein MT. ADHD: The diagnostic process from different perspectives.Dev Behav Pediatr 2004; 25: 53–57.
Cunningham CF. A large-group, community-based, family systems approach to parent training. In: Barkley RA, ed.Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis, 2d ed. New York: Guilford Press, 1998.
Swanson JM and MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in effectiveness and growth after the end of treatment.Pediatrics 2004; 113: 762–769.
Whalen CK, Henker B. Therapies for hyperactive children: Comparisons, combinations, and compromises.J Consult Clin Psychol 1991; 59(1): 126–137.
Bradley C. The behavior of children receiving benzedrine.Am J Psychiatry 1937; 94: 577–585.
Clarke SD. ADHD in adolescence.J Adolesc Health 2000; 127: 77–78.
Pliszka SR, Greenhill LL, Crismon MLet al. The Texas children’s medication algorithm project: report of the texas consensus conference panel on medication treatment of childhood, attention-deficit/hyperactivity disorder. Part I.J Am Acad Child Adolesc Psychiatry 2001; 39: 908–919.
Rappley MD. ADHD.N Engl J Med 2005; 352: 123–125.
Schubiner H, Robin AL, Young J. Attention-deficit/ hyperactivity disorder in adolescent males.Adolesc Med 2003; 14: 663–676.
Wender EH. Managing stimulant medication for attention-deficit/hyperactivity disorder: An update.Pediatr Rev 2002; 23: 234–236.
Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CKet al. Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and applications for primary care providers.J Dev Behav Pediatr 2001; 22: 60–73.
Solanto MV, Arnsten AFT, Castellanos FX. The neuroscience of stimulant drug action in ADHD. In Solanto MV, Arnsten AFT, Castellanos FX, eds.Stimulant Drugs and ADHD. London; Oxford University Press, 2001; 355–379.
Varley C: Sudden death of a child treated with imipramine.J Child Adolesc Psychopharmacol 2000; 10: 321–325.
Varley CK. Sudden death related to selected tricyclic antidepressants in children: Epidemiology, mechanisms and clinical implications.Paediatr Drugs 2001; 3: 613–627.
Atomoxerine: Strattera revisited.Med Lett 2004; 46 : 65.